A large positive is the DEP Doxetaxel update about the interim efficacy signals and 70% recruitment completed of the initial cohort.
Just a pity there are no stats on the % of the cohort that are showing the positive efficacy signals from what I could see on a brief scan.
Positve news is good news however.
I love the new layout and detail of the report, LOVE IT.
Great to see more news on the Radiothimamajig and the Eye drops.
I think a lot of the questions previously prepared on the forum still stand regarding the poor communication, AZD0466 delay, Fluerstat delay.
Overall however the report is good and I hope question time gets the answers we all have been grumbling on about.
Why they are not using near future, soon, imminent for the FDA approval and US Distribution deal is beyond me, it would actually seem warranted, so what is going on.
